AzurRx Biopharma Inc.

03/31/2021 | Press release | Distributed by Public on 03/31/2021 14:11

AzurRx BioPharma to Report Topline Data from Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis